CLEAN CELLS
Other
CLEAN CELLS
Description
Clean Cells is a subsidiary of Clean Biologics. It offers quality control and biological
safety tests for biopharmaceutical products to assist in regulatory compliance,
production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure
storage for these products and development and validation of bespoke analysis tools.
The company was created in 2000 when three biologists from the AventisâInstitut de
France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is
now one of the largest European companies within this sector. Its strong customer focus
and sizable product catalog (which expands annually) have made it a key player in the
development of novel treatments and in personalized medicine. Clean Cells also stands
out for its ability to react and adapt to its customersâ needs and the transparency of its
production and quality control processes.
safety tests for biopharmaceutical products to assist in regulatory compliance,
production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure
storage for these products and development and validation of bespoke analysis tools.
The company was created in 2000 when three biologists from the AventisâInstitut de
France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is
now one of the largest European companies within this sector. Its strong customer focus
and sizable product catalog (which expands annually) have made it a key player in the
development of novel treatments and in personalized medicine. Clean Cells also stands
out for its ability to react and adapt to its customersâ needs and the transparency of its
production and quality control processes.
Referent Contact
Ophélie BONNIN
obonnin@clean-cells.com
Resources
CLEAN CELLS
Address
4 Rue Nicolas Sadi Carnot - ZA du Point du Jour
85600 MONTAIGU-VENDEE, Vendée, France
85600 MONTAIGU-VENDEE, Vendée, France
Contact
obonnin@clean-cells.com
Description
Clean Cells is a subsidiary of Clean Biologics. It offers quality control and biological
safety tests for biopharmaceutical products to assist in regulatory compliance,
production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure
storage for these products and development and validation of bespoke analysis tools.
The company was created in 2000 when three biologists from the AventisâInstitut de
France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is
now one of the largest European companies within this sector. Its strong customer focus
and sizable product catalog (which expands annually) have made it a key player in the
development of novel treatments and in personalized medicine. Clean Cells also stands
out for its ability to react and adapt to its customersâ needs and the transparency of its
production and quality control processes.
safety tests for biopharmaceutical products to assist in regulatory compliance,
production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure
storage for these products and development and validation of bespoke analysis tools.
The company was created in 2000 when three biologists from the AventisâInstitut de
France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is
now one of the largest European companies within this sector. Its strong customer focus
and sizable product catalog (which expands annually) have made it a key player in the
development of novel treatments and in personalized medicine. Clean Cells also stands
out for its ability to react and adapt to its customersâ needs and the transparency of its
production and quality control processes.
Resources
Matchmaking
Connect with CLEAN CELLS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
Partnership needs
-
Business Development
